ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

VRCA Company Profile and Key Details

NASDAQ : VRCA

Verrica Pharmaceuticals Inc.

$0.65

0.1153+21.75%

At Close 4:00 PM

$0.58

−0.0654-10.13%

After-Market 08:30 PM

66.73

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

VRCA Stock Price Chart

Stock Price Today

Verrica Pharmaceuticals Inc. (VRCA) stock surged +21.75%, trading at $0.65 on NASDAQ, up from the previous close of $0.53. The stock opened at $0.53, fluctuating between $0.46 and $0.65 in the recent session.

Stock Snapshot

0.5301

Prev. Close

0.53

Open

59.23M

Market Cap

91.78M

Number of Shares

0.4596

Day Low

0.65

Day High

-0.44

P/E Ratio

54.14%

Free Float in %

-1.48

EPS (TTM)

0.43

Book Value

-0.85

Cash Flow per Share

1.44M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 07, 2025	0.53	0.65	0.46	0.65	1.45M
Apr 04, 2025	0.41	0.54	0.40	0.53	781.93K
Apr 03, 2025	0.42	0.43	0.38	0.42	357.12K
Apr 02, 2025	0.44	0.45	0.40	0.44	412.78K
Apr 01, 2025	0.44	0.44	0.40	0.42	363.23K
Mar 31, 2025	0.43	0.45	0.39	0.44	532.76K
Mar 28, 2025	0.44	0.47	0.42	0.43	392.81K
Mar 27, 2025	0.45	0.47	0.43	0.44	250.05K
Mar 26, 2025	0.48	0.49	0.42	0.44	613.2K
Mar 25, 2025	0.52	0.55	0.46	0.48	664.35K
Mar 24, 2025	0.58	0.61	0.50	0.52	540.57K
Mar 21, 2025	0.60	0.66	0.56	0.56	2.62M
Mar 20, 2025	0.62	0.63	0.59	0.61	359.42K
Mar 19, 2025	0.65	0.67	0.60	0.62	273.83K
Mar 18, 2025	0.64	0.68	0.60	0.65	517.12K
Mar 17, 2025	0.52	0.66	0.51	0.65	636.04K
Mar 14, 2025	0.58	0.59	0.54	0.54	392.24K
Mar 13, 2025	0.60	0.62	0.56	0.59	300.9K
Mar 12, 2025	0.63	0.63	0.54	0.60	784.56K
Mar 11, 2025	0.66	0.68	0.61	0.65	404.7K

Contact Details

West Chester, PA 19380

United States

Website: https://www.verrica.comContact: 484 453 3300

About Company

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is in Phase II clinical trial for treating common warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatological oncology indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.

Stock Peers

REGN

-0.67-0.12%

Regeneron Pharmaceuticals, Inc.$572.78 ARGX

-5.11-0.92%

argenx SE$550.00 VRTX

-0.06-0.01%

Vertex Pharmaceuticals Incorporated$474.56 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 MDGL

-3.87-1.23%

Madrigal Pharmaceuticals, Inc.$310.52 UTHR

-0.74-0.25%

United Therapeutics Corporation$291.72 ALNY

-2.79-1.18%

Alnylam Pharmaceuticals, Inc.$232.95 SGEN

-0.16-0.07%

Seagen Inc.$228.74 BGNE

0.9+0.49%

BeiGene, Ltd.$184.71 RETA

0.04+0.02%

Reata Pharmaceuticals, Inc.$172.36

Frequently Asked Questions

What is the current Verrica Pharmaceuticals Inc. (VRCA) stock price?

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) stock price is $0.65 in the last trading session. During the trading session, VRCA stock reached the peak price of $0.65 while $0.46 was the lowest point it dropped to. The percentage change in VRCA stock occurred in the recent session was 21.75% while the dollar amount for the price change in VRCA stock was $0.12.

VRCA's industry and sector of operation?

The NASDAQ listed VRCA is part of Biotechnology industry that operates in the broader Healthcare sector. Verrica Pharmaceuticals Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of VRCA?

Mr. Joe Bonaccorso
Chief Commercial Officer
Mr. Ted White
Pres, Chief Executive Officer & Director
Dr. Gary Goldenberg M.D.
Chief Medical Officer
Mr. P. Terence Kohler
Chief Financial Officer
Mr. Christopher G. Hayes
Chief Legal Officer, Sec., Chief Compliance Officer & Gen. Counsel
Mr. Eugene Scavola
Executive Vice President of Technical Operations
Dr. Bradley J. Catalone MBA, Ph.D.
Head of Drug Devel.

How VRCA did perform over past 52-week?

VRCA's closing price is 68.95% higher than its 52-week low of $0.38 where as its distance from 52-week high of $11.41 is -94.34%.

How many employees does VRCA have?

Number of VRCA employees currently stands at 71.

Link for VRCA official website?

Official Website of VRCA is: https://www.verrica.com

How do I contact VRCA?

VRCA could be contacted at phone 484 453 3300 and can also be accessed through its website. VRCA operates from 44 West Gay Street, West Chester, PA 19380, United States.

How many shares of VRCA are traded daily?

VRCA stock volume for the day was 1.44M shares. The average number of VRCA shares traded daily for last 3 months was 396.19K.

What is the market cap of VRCA currently?

The market value of VRCA currently stands at $59.23M with its latest stock price at $0.65 and 91.78M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	71
Beta	1.45
Sales or Revenue	$5.12M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology